Supernus Pharmaceuticals (SUPN) Deferred Taxes (2016 - 2026)
Supernus Pharmaceuticals (SUPN) reported Deferred Taxes of $5.9 million for Q1 2026, up 248.27% year-over-year from $1.7 million in Q1 2025, and down 68.87% quarter-over-quarter from $19.0 million in Q4 2025.
Supernus Pharmaceuticals (SUPN) Deferred Taxes (2016 - 2026) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 11 years of Deferred Taxes data on file, last reported at $5.9 million in Q1 2026.
- Deferred Taxes for Q1 2026 came in at $5.9 million, up 248.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.1 million (up 181.06% YoY), and the FY2025 annual result was $5.2 million, up 125.85% from the prior year.
- Deferred Taxes fell to $5.9 million in Q1 2026 per SUPN's latest filing, from $19.0 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $19.0 million in Q4 2025 and troughed at -$13.0 million in Q1 2022.
- A 5-year average of -$3.6 million and a median of -$5.5 million in 2024 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2024 and 2025: Deferred Taxes sank 1160.23% in 2024, then soared 26493.06% in 2025.
- A 5-year view of Deferred Taxes shows it stood at -$7.8 million in 2022, then sank by 34.78% to -$10.5 million in 2023, then jumped by 99.31% to -$72000.0 in 2024, then soared by 26493.06% to $19.0 million in 2025, then slumped by 68.87% to $5.9 million in 2026.
- Business Quant data shows SUPN's Deferred Taxes at $5.9 million in Q1 2026, $19.0 million in Q4 2025, and -$2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 19.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -13.98 Mn |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - | 5.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.92 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Sep 30, 2025 | -2.65 Mn |
| Jun 30, 2025 | -7.16 Mn |
| Mar 31, 2025 | -3.99 Mn |
| Dec 31, 2024 | -72,000.00 |
| Sep 30, 2024 | -6.47 Mn |
| Jun 30, 2024 | -8.12 Mn |
| Mar 31, 2024 | -5.48 Mn |
| Dec 31, 2023 | -10.46 Mn |
| Sep 30, 2023 | -9.27 Mn |
| Jun 30, 2023 | -5.55 Mn |
| Mar 31, 2023 | -435,000.00 |
| Dec 31, 2022 | -7.76 Mn |
| Sep 30, 2022 | -2.51 Mn |
| Jun 30, 2022 | -3.05 Mn |
| Mar 31, 2022 | -13.01 Mn |
| Dec 31, 2021 | -4.52 Mn |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 519,000.00 |